Del-Sette Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Del-Sette Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-39,747	Closed	-$3.15M	–	36
2022 Q3	$3.15M	Buy	39,747 +8,638	+28%	+$728K	3.73%	6
2022 Q2	$2.31M	Buy	+31,109	New	+$2.34M	2.63%	6

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

MCM

Moore Capital Management New York $4.92B AUM 35.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.57B AUM 15.23% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Del-Sette Capital Management's XBI Position: Q4 2022 in Review

Del-Sette Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2022, closing a stake of 39,747 shares — an estimated $3.15M sold.

Del-Sette Capital Management first reported a position in XBI in Q2 2022 and held it in 2 quarters. The position peaked at $3.15M in Q3 2022. 746 funds tracked by Wall St. Rank hold XBI as of Q4 2022.

Del-Sette Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2022 after selling out during the quarter.
Del-Sette Capital Management sold 39,747 State Street SPDR S&P Biotech ETF shares in Q4 2022, an estimated $3.15M.
Del-Sette Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2022 and held it in 2 quarters.
Del-Sette Capital Management's State Street SPDR S&P Biotech ETF position peaked at $3.15M in Q3 2022.
746 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2022.

Based on Del-Sette Capital Management's 13F filing for Q4 2022, filed 24 Jan 2023.